Article
Achieving Launch Excellence in the Evolving Obesity Market
May 16, 2025
This industry article as featured in PharmaLive and authored by IQVIA experts Sarah Rickwood, VP, EMEA Thought Leadership, and Natalie Harb, VP, Global Commercial Solutions, Global Launch Excellence explores how therapies for obesity are poised to become one of the most significant new therapeutic categories in decades, presenting unparalleled opportunities and unique challenges. It discusses how companies that navigate challenges while focusing on patient needs and healthcare readiness, maintaining flexibility, and building robust data capabilities will be best positioned to achieve launch excellence in this obesity market.

Related solutions

Contact Us
OSZAR »